Latest From Biotech Now

BioFlorida Conference: Here’s What You Missed

Isaac Ro, Goldman Sachs

As I mentioned last week, BIO President & CEO James C. Greenwood kicked-off  this week’s BioFlorida 14th Annual Conference with a keynote speech. Thanks to @BioFlorida2011 for tweeting some of his speech highlights. If you were not able to make it to Tampa for the conference, fear not, I’ve got you covered. Here’s a rundown of some of the things you missed: It’s All About Efficiency, Innovation and Globalization Goldman Sachs equity analyst Isaac Ro Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Bioenergy Business Outlook Survey Measures Industry Confidence

Biofuel Research

Biofuels Digests’ Bioenergy Business Outlook Survey, co-sponsored by BIO, is a quarterly indicator of business confidence, financial outlook and growth intentions. The results of the survey provide valuable insight into the mood of leaders in the bioenergy industry. More than a third of respondents each quarter identify themselves as chief executive or owner of their business. Nearly two-thirds of respondents identify themselves as directly involved in bioenergy production, either as producers, investors, business partners or Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Investor Forum Company Snapshot: Protagonist Therapeutics

Protagonist

In our final Investor Forum Company Snapshot, we’ve profiled one of the Discovery Companies who will be presenting at the event. Protagonist Therapeutics shares their take on funding challenges and upcoming priorities, plus interesting facts about their company. Don’t miss their presentation first thing Tuesday morning! Company Snapshot What are the short-term and long-term priorities for your company? Protagonist is a peptide therapeutics based technology platform company. Short term priority:  Secure a second collaboration and Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

EU Stem Cell Patent Decision Hurts Science

Æ

A great article in the Economist titled European science stemmed addresses the recent and controversial decision by the European Court of Justice regarding the patentability of certain inventions derived from embryonic stem cells. ANY country, you might think, would relish being able to call itself the world’s leader in scientific research. America and Europe, however, seem to be in a bizarre parallel contest: which can make its scientists’ lives more difficult by imposing the most muddled Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BioFlorida’s Conference to Focus on Latest Technologies, Access to Capital

BFAC

BIO President & CEO James C. Greenwood will commence next week’s BioFlorida 14th Annual Conference with a keynote speech at 8AM on Monday October 24, 2011 in Tampa, FL. Living up to its reputation as the premier business development, investing and networking event for Florida’s bioscience industry, more than 500 business, science and technology leaders are expected to attend the three-day conference, which runs Oct. 23-25 at the Marriot Waterside Hotel & Marina. This year’s Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,